Jump to Main Content
A Portable Device for Rapid Detection of Human Serum Albumin using an immunoglobulin-coating-based Magnetoelastic Biosensor
- Sang, Shengbo, Li, Yuchao, Guo, Xing, Zhang, Bo, Xue, Xianwei, Zhuo, Kai, Zhao, Chun, Zhang, Wendong, Yuan, Zhongyun
- Biosensors & bioelectronics 2019 v.141 pp. 111399
- antibodies, antigens, biosensors, blood serum, cost effectiveness, detection limit, human serum albumin, humans, immunoglobulin G, portable equipment, quantitative analysis, rapid methods, urine
- Abnormal protein concentration levels in human body fluids, such as urine, serum etc., are considered to associate with disease states, providing essential information for the pre-clinical diagnosis. This paper presents a wireless immunoglobulin-coated magnetoelastic (ME) biosensor for fast, cost-effective detections of human serum albumin (HSA) with small sample volumes at a microliter scale. This is the first portable resonant sensor based on magnetostrictive effect that can monitor different molecular states of HSA. Anti-HSA Immunoglobulin G (IgG) was immobilized on the surface of the ME sensor to selectively capture HSA. The rapid conjugation between the antibody and antigen changed the sensor surface states and thus induced resonance frequency shifts (RFS), which were monitored in real time for the qualitative and quantitative analysis of HSA. This paper brings forward a System on Chip (SoC)-based system architecture to realize the function of RFS sampling. The performance of the portable device was validated to be comparable to that of the Vector Network Analyzer (VNA) AV3620 using different concentrations of HSA solution. The RFS were linearly proportional to the HSA concentrations in the range from 0.1 to 100 μg/mL with a linearity up to 0.998, a sensitivity of 8.70 Hz/μg.mL-1 and a detection limit of 0.039 μg/mL, indicating good feasibility of this method. Meanwhile, the response of this portable ME biosensor was quick and specific to HSA targets. This ME biosensor shows high potential to be used in diagnosing abnormal HSA.